An international investment group led by Life Sciences Partners (LSP) of the Netherlands has provided $45 million in Series D financing to the digital health company Endotronix Inc to commercialise its system for helping physicians treat patients with heart failure from home.
The product platform consists of a remote monitoring system coupled with an implantable pulmonary artery sensor that enables physicians to monitor their patients and detect any worsening of a heart failure.